|
MTA2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.257800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.959400E-01 |
| Normal-vs-Stage2 |
8.472600E-01 |
| Normal-vs-Stage3 |
1.874410E-01 |
| Normal-vs-Stage4 |
6.199000E-01 |
| Stage1-vs-Stage2 |
8.016200E-01 |
| Stage1-vs-Stage3 |
3.650200E-01 |
| Stage1-vs-Stage4 |
7.895400E-01 |
| Stage2-vs-Stage3 |
3.513000E-01 |
| Stage2-vs-Stage4 |
6.823200E-01 |
| Stage3-vs-Stage4 |
7.798600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.926600E-01 |
| Normal-vs-AfricanAmerican |
2.940400E-01 |
| Normal-vs-Asian |
2.739900E-02 |
| Caucasian-vs-AfricanAmerican |
6.209800E-01 |
| Caucasian-vs-Asian |
1.891610E-01 |
| AfricanAmerican-vs-Asian |
1.989580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.433400E-01 |
| Normal-vs-Female |
3.570400E-02 |
| Male-vs-Female |
4.738000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.655400E-01 |
| Normal-vs-Extreme_Weight |
8.513200E-01 |
| Normal-vs-Obese |
8.248100E-02 |
| Normal-vs-Extreme_Obese |
1.810770E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.433400E-01 |
| Normal_Weight-vs-Obese |
2.926000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.436020E-01 |
| Extreme_Weight-vs-Obese |
8.191500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.142600E-01 |
| Obese-vs-Extreme_Obese |
5.201500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.575100E-03 |
| Normal-vs-Age(41-60Yrs) |
1.175630E-01 |
| Normal-vs-Age(61-80Yrs) |
6.944400E-01 |
| Normal-vs-Age(81-100Yrs) |
7.184100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.629990E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.471800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.897140E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.625900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.744300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.168790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.041400E-01 |
| Normal-VS-Type2 PRCC |
5.763600E-02 |
| Normal-VS-KIRP CIMP |
4.31340000000002E-05 |
| Normal-VS-Unclassified PRCC |
3.101000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.8245799999983E-05 |
| Type1 PRCC-VS-KIRP CIMP |
4.437700E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
9.471600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.10659999946949E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
3.975900E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
6.399800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.525400E-01 |
| Normal-vs-N1 |
3.909600E-02 |
| Normal-vs-N2 |
6.194000E-01 |
| N0-vs-N1 |
2.209900E-02 |
| N0-vs-N2 |
7.306400E-01 |
| N1-vs-N2 |
2.234600E-01 |
|
|
